Delivery Order SPE2DB20D1004-SPE2DB24FF9W1

Award Date 5/7/24
Potential Completion Date 5/8/24
Potential Value $4.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,389.72, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 21, 2024, and is a firm-fixed-price contract. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,266.89, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of January 8, 2025 and is a firm fixed-price arrangement. There is no set-aside designation noted for this contract. AmerisourceBergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,587.81, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of September 20, 2023. AmerisourceBergen is the prime contractor, and there is no set-aside designation for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply DIFICID 200 MG TABLET 20S. The contract has a firm fixed price ceiling value of $31,559.64 and an ultimate completion date of August 27, 2024. This order is not associated with a set-aside program. AmerisourceBergen has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,355.83 delivery order contract is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 17, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DIFICID 200 MG TABLET 20S. The $3,217.73 firm fixed-price contract has an ultimate completion date of April 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,519.99 fixed-price contract is for the supply of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 4, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,595.72 firm fixed-price contract is for the supply of DIFICID 200 MG TABLET 20S, with a performance period ending on May 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,739.00, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract is a Delivery Order and has a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of January 7,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,314.28, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 10, 2025. The award is not associated with a set-aside designation, indicating open competition....
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF9W1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,422.90, is for the delivery of DIFICID 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of May 8, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award reviewed was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 1:23 PM